Literature DB >> 22503545

PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRα through the IGF-I-mediated signaling pathway.

Shi-Lin Tang1, Wu-Jun Chen, Kai Yin, Guo-Jun Zhao, Zhong-Cheng Mo, Yun-Cheng Lv, Xin-Ping Ouyang, Xiao-Hua Yu, Huai-Jun Kuang, Zhi-Sheng Jiang, Yu-Chang Fu, Chao-Ke Tang.   

Abstract

Pregnancy-associated plasma protein-A (PAPP-A) has been involved in the atherosclerotic process through regulation of local expression of IGF-1 that mediates the activation of the phosphatidylinositol-3 (PI3-K) and Akt kinase (Akt) signaling cascades which lead to constitutive nitric oxide formation, with its attending vasodilator, antiplatelet and insulin-sensitizing actions. In addition, IGF-1 may decreased cholesterol efflux through reductions of expression in ABCA1 and SR-B1 by the PI3-K/Akt signaling pathway. In the current study, we examined whether PAPP-A was involved in LXRα regulation and in expression of ABCA1, ABCG1 or SR-B1 through the IGF-I-mediated signaling pathway (IGF/PI3-K/Akt). Results showed that PAPP-A significantly decreased expression of ABCA1, ABCG1 and SR-BI at both transcriptional and translational levels in a dose-dependent and time-dependent manner. Cellular cholesterol content was increased while cholesterol efflux was decreased by PAPP-A treatment. Moreover, LXRα which can regulate the expression of ABCA1, ABCG1 and SR-B1, was also down-regulated by PAPP-A treatment. LXRα-specific activation by LXRα agonist almost rescued the down-regulation of ABCA1, ABCG1 and SR-B1 expression by PAPP-A. In addition, PAPP-A can induce the IGF-1/PI3-K/Akt pathway in macrophages. Furthermore, our results indicate that the decreased levels observed in LXRα, ABCA1, ABCG1 and SR-B1 mRNA and protein levels upon treating cells with PAPP-A were strongly impaired with the PI3-K inhibitors or IGF-1R siRNA while the MAPK cascade inhibitor did not execute this effect, indicating that the process of ABCA1, ABCG1 and SR-BI degradation by PAPP-A involves the IGF-1/PI3-K/Akt pathway. In conclusion, PAPP-A may first down-regulate expression of LXRα through the IGF-1/PI3-K/Akt signaling pathway and then decrease expression of ABCA1, ABCG1, SR-B1 and cholesterol efflux in THP-1 macrophage-derived foam cells. Therefore, our study provided one of the mechanisms for understanding the critical effect of PAPP-A in pathogenesis of atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503545     DOI: 10.1016/j.atherosclerosis.2012.03.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

1.  Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.

Authors:  Matej Mihelčić; Goran Šimić; Mirjana Babić Leko; Nada Lavrač; Sašo Džeroski; Tomislav Šmuc
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 2.  Mechanisms of foam cell formation in atherosclerosis.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  J Mol Med (Berl)       Date:  2017-08-07       Impact factor: 4.599

Review 3.  Regulatory T cells as a new therapeutic target for atherosclerosis.

Authors:  Han-Xiao Ou; Bing-Bing Guo; Qi Liu; Yu-Kun Li; Zhen Yang; Wen-Jie Feng; Zhong-Cheng Mo
Journal:  Acta Pharmacol Sin       Date:  2018-01-11       Impact factor: 6.150

4.  Baicalin promotes cholesterol efflux by regulating the expression of SR-BI in macrophages.

Authors:  Renchao Yu; Yuexia Lv; Juanling Wang; Nana Pan; Rui Zhang; Xiaxia Wang; Haichu Yu; Lijuan Tan; Yunhe Zhao; Bo Li
Journal:  Exp Ther Med       Date:  2016-11-08       Impact factor: 2.447

5.  Overexpression of miR-223 inhibits foam cell formation by inducing autophagy in vascular smooth muscle cells.

Authors:  Weibin Wu; Zhen Shan; Rui Wang; Guangqi Chang; Mian Wang; Ridong Wu; Zilun Li; Chunxiang Zhang; Wen Li; Shenming Wang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

6.  Deficiency of brain ATP-binding cassette transporter A-1 exacerbates blood-brain barrier and white matter damage after stroke.

Authors:  Xu Cui; Michael Chopp; Alex Zacharek; Joanna M Karasinska; Yisheng Cui; Ruizhuo Ning; Yi Zhang; Yun Wang; Jieli Chen
Journal:  Stroke       Date:  2015-01-15       Impact factor: 7.914

7.  Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet.

Authors:  Cheryl A Conover; Sara L Harstad; Tamar Tchkonia; James L Kirkland
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-17       Impact factor: 4.310

8.  Endurance training enhances LXRα gene expression in Wistar male rats.

Authors:  Fatemeh Kazeminasab; Mohammad Marandi; Kamran Ghaedi; Fahimeh Esfarjani; Jamal Moshtaghian
Journal:  Eur J Appl Physiol       Date:  2013-05-15       Impact factor: 3.078

9.  Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt-NF-κB axis.

Authors:  Plinio Cirillo; Stefano Conte; Grazia Pellegrino; Francesca Ziviello; Giusi Barra; Raffaele De Palma; Antonio Leonardi; Bruno Trimarco
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

10.  Angiotensin II induces cholesterol accumulation and impairs insulin secretion by regulating ABCA1 in beta cells.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Seisuke Sato; Tomohiro Ibata; Toshihiro Kobayashi; Tao Dong; Takuo Yoshimoto; Kazuko Yonezaki; Hiromi Nagata; Hisakazu Iwama; Koji Murao
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.